REST and medical procedure: The oncogenic function of REST was identified in medulloblastoma16, 17 and glioblastoma18, while the tumor suppressor role of REST was elucidated in colorectal cancer19, 20, breast cancer21, 22, PCa9, 10, 11, 12, 13 and small cell lung cancer (SCLC)23, 24.